CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 90 enrolled
Drug / intervention
sufficient dose of rocuronium +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02724111
NCT02724111Phase 4Completed

Comparison of Operating Conditions, Postoperative Recovery and Overall Satisfaction Between Deep and Restricted Neuromuscular Blockade for Spinal Surgery Under General Anesthesia

Korea University Guro Hospital·interventional·Posted Mar 31, 2016·Updated Oct 13, 2017

In Brief

A Phase 4 clinical trial evaluating sufficient dose of rocuronium and sugammadex 10 min after position change for Neuromuscular Blockade and 3 related conditions. Completed, enrolled 90 participants across 1 site.

Detailed Summary

The investigators aim to investigate operating conditions, postoperative recovery and overall satisfaction of surgeons between deep neuromuscular blockade (NMB) group and restricted NMB group during spinal surgery under general anesthesia. The investigators hypothesize that this study can present good surgical conditions, postoperative recovery outcomes and overall satisfaction of surgeons in deep NMB group, thereby proving the advantages of deep NMB as well as flaws of restricted NMB in spine surgeries.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSouth Korea

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 31, 2016
Enrollment StartMay 15, 2016
Primary CompletionFeb 16, 2017
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 10.3 years ago

Interventions

sufficient dose of rocuroniumdrug

sugammadex 10 min after position changedrug